T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results


Achieved record fourth quarter and full-year 2024 sepsis product revenues Achieved record fourth quarter and full-year 2024 sepsis product revenues

Read more here:
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results

Related Posts